Pure Global AI
NCT06312124Recruiting

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

A Multi-Disciplinary Approach to the Opportunistic Salpingectomy for Primary Prevention of Ovarian Cancer
Memorial Sloan Kettering Cancer CenterClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Surgery
Drug/Device/Intervention
Educational Module
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Memorial Sloan Kettering Cancer Center
Location
Baltimore,Boston,Basking Ridge,Middletown,Montvale,Commack,Harrison,New York,Uniondale,Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2024
End date
Mar 08, 2028
Enrollment
400 participants
Primary outcome

Rate of Opportunistic Salpingectomy/OS after completion of educational module

Summary

The purpose of this study is to find out how many participants are interested in a surgical
 preventive procedure after watching an educational video. Before and after watching the
 video, participants will complete questionnaires in the clinic.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06312124
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06312124 through Pure Global AI's free database. This phase not specified trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Surgery. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.